Retina

Gildeuretinol halts Stargardt disease progression, study results indicate

The online tool shows vision loss simulations for diabetic macular oedema, diabetic retinopathy, age-related macular degeneration and other retinal diseases

Prof Tadayoni was a much-admired leader, researcher, surgeon and EURETINA President

Zeiss has secured regulatory approvals to acquire DORC and will shift focus to integration implementation

Multimodal imaging and a systemic work-up failed to identify any underlying disorder for the hemorrhages

In addition to the primary safety and tolerability endpoints, the study also saw signals of biological response from EXN407

Good news for patients: use of anti-complement therapies have caused the growth rate of GA lesions to decrease

Retina specialists Giuseppe Querques, MD, PhD, and Paolo Lanzetta, MD, debate at the Congress on Controversies in Ophthalmology

At this year's Congress on Controversies in Ophthalmology, keynote speaker Ursula Schmidt-Erfurth, MD, addressed the clinical use of artificial intelligence

Kiora also stated a Phase 2 trial of KIO-104 is expected to begin later this year

The retina specialist shares advice for the clinician-scientists of a digital-centric future

A longitudinal, AI-based approach to fluid quantification

The algorithms could provide major accessibility improvements and cost savings to underdeveloped regions

The kidney and eye are structurally similar and the diseases of the organs may present via common pathways

The authors suggested genetic mutation may relax the body’s defences and allow harmful bacteria to reach the eye

The Retinopathy of Prematurity (ROP) Education and Support Programme is part of ROP Awareness Week, recognised from 26 February to 3 March

Optical coherence tomography angiography could also identify patients at risk of disease progression

Physicians explore how other specialties adopt and integrate remote monitoring

The Phase 2/3 VISTA trial for AGTC-501 in XLRP is expected to begin in in the first half of 2024

According to the company, the patent further protects Iridex’s intellectual property encompassing laser systems in ophthalmology and related fields

Toku’s AI technology, CLAiR, provides fast, accurate, non-invasive cardiovascular disease (CVD) risk assessments using standard retinal images

Ramin Tadayoni, MD, PhD, highlights data from the BALATON and COMINO Phase 3 studies about faricimab

Robyn Guymer, MBBS, PhD, reported the Voyager study’s preliminary data at the 2024 Angiogenesis, Exudation, and Degeneration conference

Dr Jennifer Lim reveals new data on Angiopoietin-2 inhibition and insights on clinical trial design

Anat Loewenstein, MD, illuminates the outcomes of using an AI-based fluid quantification for remote retina monitoring and analysis

Dr Carl Regillo provided an overview of topline results – and a deep dive into subgroup analyses – of DAVIO 2 trial data

Sydney M Crago, editor of Modern Retina, talks with Arshad M Khanani, MD, MA, FASRS, about the expanded efficacy data from the GATHER 2 trial, presented at the 2024 Angiogenesis Symposium

EODM may be an ideal candidate for development of complement gene therapy due to the high-impact genetic variants

Researchers aimed to develop a translational map to understand how advanced imaging biomarkers manifest in typical diagnostic imaging

Kiora Pharmaceuticals and Théa Open Innovation will develop and commercialise KIO-301 for the treatment of inherited retinal diseases